CYIG's Research Advances Through the Cooperation With NFU

SHANDONG, China, July 22, 2014 (GLOBE NEWSWIRE) -- China YCT International Group, Inc (OTC:CYIG) has recently held a work conference with Nanjing Forestry University (NFU). The two sides had in-depth communications about the company development and the future of acer truncatum as well as the cooperation plan.

Cao Fu Liang, Principal of the NFU stated at the conference that after several years cooperation with CYIG, both have achieved a lot of scientific goals in gingko research and production. During this time, CYIG took on some governmental programs including the national Torch Program, the Provincial and National Enriching People and County programs and were awarded a second place in the China national scientific progress prize.

As a high-tech enterprise, the Company built a technologically innovative platform consisting of provincial engineering technology research center and the preparation engineering laboratory. The researchers in the Center consist of more than 20 professionals and many other engineers of which 60% of them are senior level. The Center is equipped with provincial standardized experimental facilities and is thus suited to national and provincial research plans and tests, and sets down products techniques and processes for the Company. The Center holds 4 national invention patents.

The Laboratory contains 2 workshops. The natural medicine extraction shop is responsible for extracting, isolating and purifying the functional ingredients from the gingko aglycone flavonoids and acer truncatum at the same time. The shop can also deal with a hundred more Chinese medical herbs extraction and purification.

Based on downstream products of gingko and acer truncatum, the biological feed shop adopted biological fermentation and enzyme technology to produce antibiotic-free additives which could replace the antibiotic additives has now being widely used in cultivation industry.

Mr. Tinghe Yan,The CEO of CYIG commented that, "CYIG has grown up as time goes by and now became a famous China pharmaceutical company with rapid growth. Adhere to the enterprise purpose of 'casting quality and building the brand in the future, CYIG is stepping onto the worldwide stage and embracing the new period of fast development."

With the development of our society and the evolvement of the human being, health has became the most concerned thing. CYIG views the public healthcare as its duty and therefore helps people by their various kind of medicine products to make a better society and world.

The Strategy leads the development and innovation drives the progress. Under the Five Years Development Plan of CYIG, the company implements the strategy for the project to rapidly expand the business scale and market share. We will carry forward the company's advanced culture, strive to explore a new business model, commit to the enterprise long-term value creation, and provide consumers good quality and efficient products and services. Meanwhile, we will actively fulfill the social responsibility, return our shareholders, customers, society and employees with fruitful results from the development of enterprise, realize the aim of 'the pursuit of profits'".

For more information, visit

Safe Harbor Statement

Certain statements in this press release, constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These statements include, without limitation, statements regarding the Company's future performance. The Company has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the periodic reports that are filed with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. The Company undertakes no duty to update these forward-looking statements except as required by law.

CONTACT: Zecheng Shao Tel: 0086-537-4268276 Email: zecheng.shao@gmail.comSource:China YCT International Group